EULAR welcomes the new chairs and chairs-elect

• The Advocacy Committee Chair: Margreet Kloppenburg

• The Quality of Care Committee Chair-Elect: George Fragoulis

• The Research Committee Chair-Elect: Anna Molto

• The Congress Committee Chair-Elect: Xenofon Baraliakos

• The Education Committee Chair-Elect: Francisca Sivera

• The EMerging Eular NETwork Committee Chair-Elect: Diego Benavent

• The PAED Committee Chair-Elect: Jordi Anton

European Alliance of Associations for Rheumatology (EULAR) extends its warm appreciation to the past-chairs for their commitment, unwavering support and dedication! Homepage %7C EULAR

The latest recommendations from EULAR

• EULAR recommendations for the involvement of patient research partners in rheumatology research (2023 update): EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update %7C Annals of the Rheumatic Diseases (bmj.com).

• EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies (2023 update): EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update %7C Annals of the Rheumatic Diseases (bmj.com).

For recommendations relevant to patient audiences, EULAR provides a lay summary version in English and calls on all interested organisations to disseminate them and encourage the translation into their own language:

• EULAR recommendations for the involvement of patient research partners in rheumatology research (2023 update): DE WIT lay summary v1 05June24 MdW_AG revEM AL.pdf (eular.org).

Find more EULAR recommendations at EULAR %7C Recommendations and initiatives.

Thank you for another outstanding EULAR 2024 Congress experience!

We extend our heartfelt thank you to all who joined us at the EULAR 2024 Congress in Vienna! It was a pleasure to host over 12 000 delegates, providing an enriching environment to connect, collaborate and share insights with the rheumatology community. Our dynamic programme featured 136 scientific sessions led by more than 400 distinguished speakers and chairs, enriching understanding and sparking dialogues across the field. With a record-breaking number of over 5200 abstracts submitted, the EULAR 2024 Congress was a hub of innovative research, networking and latest developments in rheumatology. Thank you for making EULAR 2024 another great success!

EULAR 2024 is available online on-demand until 31 December 2024!

The Scientific Programme (excluding Posters and Meet the EULAR Expert sessions) from the EULAR 2024 Congress remains accessible online for all registered participants until 31 December. This extensive resource includes sessions on basic, clinical and translational research alongside educational content covering a wide array of topics in rheumatology. This is an excellent opportunity to revisit cutting-edge insights at your own pace.

The on-demand registration is open until 30 June 2024: EULAR 2024 - Registration.

From the heart of Vienna to the coast of Barcelona—EULAR 2025 Congress!

Save the date and visit us at the next EULAR European Congress of Rheumatology in Barcelona, on 11–14 June 2025.

The key dates for EULAR 2025 are available in the EULAR 2025 Timeline.

The EULAR Manifesto 2024–2029 advocates for a united European strategy to tackle the extensive health and socioeconomic impacts of rheumatic and musculoskeletal diseases

Rheumatic and musculoskeletal diseases (RMDs) can occur at any age, including in children and young adults, but disproportionately affect the elderly, women and the socioeconomically vulnerable. Europe’s ageing population and negative lifestyle trends mean more people are experiencing the devastating impacts of these diseases. We need a strategy to reduce the burden of RMDs on businesses and address the impact of an ageing population and shrinking workforce on Europe’s economy. Europe must therefore promote an innovative, cost-effective, multidisciplinary RMD treatment model to maintain the sustainability of our threatened healthcare and social systems.

EULAR’s 2024–2029 Manifesto calls for a unified European effort to mitigate the impact of RMDs on European citizens, health and social care systems, and the broader economy. Focusing on improving quality of care, research and social policy relating to RMDs, the EULAR Manifesto aims to provide a blueprint for how the European Union (EU) can tackle these widespread and serious diseases, which touch the lives of almost every EU citizen at some point. The suggestions in the Manifesto can also be used at the member state level: EULAR Manifesto %7C EULAR.

EULAR has announced new application criteria to become a centre of excellence in rheumatology research

The EULAR Centres of Excellence are top-tier rheumatology research centres from across Europe, fostering collaboration among leading researchers and enabling the exchange of first-class science. Centres can apply for this prestigious recognition that will be valid for 5 years. In 2025, EULAR will introduce new application criteria for centres to demonstrate their significant contributions to the field. The new application criteria will be available on the EULAR website as of November 2024: EULAR Centres of Excellence %7C EULAR.

EULAR launches first European patient-filled survey about the impact of RMDs

The EULAR Impact of RMDs Survey gathers essential data directly from people with RMDs across EULAR-affiliated countries. Through periodical questionnaires, patients share their healthcare experiences and describe how RMDs affect their lives. These data will support advocacy efforts and provide researchers, healthcare professionals and patients with crucial insights into the disease burden, ultimately improving care for all those affected. EULAR invites all patients, as well as physicians and healthcare professionals who see patients with RMDs, to take part in this survey: EULAR Impact of RMDs Survey.

EULAR develops a European network of clinical trial centres

Focused on facilitating RMD-related clinical trials, EULAR Network of TRIal centres (ENTRI) aims to create a network of clinical trial centres accessible to all investigators. By facilitating the delivery of incisive research studies, ENTRI will help generate the evidence required to implement changes in clinical practice that are meaningful and beneficial to patients. EULAR invites institutions to join the ENTRI Clinical Trial Network through a two-step application process starting with a simple expression of interest: ENTRI %7C EULAR

EULAR School of Rheumatology: Registration to online courses now open

12 EULAR online courses are available for registration until 1 November: Find learning (eular.org). Long-term and short-term training grants are also available to young fellows in Europe, seeking to visit a training facility in another European country: Grants and exchange.

EULAR HPR: The EULAR Health Professionals Research Grant

Every year, EULAR funds one Health Professional Research project in the field of RMDs. The call is open from 16 September 2024: Health Professionals Research Grant %7C EULAR.

Stay up to date about EULAR’s activities and communities by subscribing to our dedicated newsletters

EULAR curates various newsletters to keep our audiences informed and engaged with our latest activities and initiatives. Our most recent launch is the new PAED newsletter, which provides quarterly updates particularly relevant to the field of paediatric rheumatology. See the full list and subscribe to your preferred mailing on Homepage %7C EULAR.

Foreum Foundation for Research in Rheumatology is announcing the launch of its next calls for research proposals:

1. Interdisciplinary call with the European Academy of Dermatology and Venereology will be launched on Friday, 30 August 2024. More information here FOREUM – FOREUM/RRF Partnership Award.

2. Topic call on ‘Applied omics approaches to address unmet clinical needs in RMDs’ will be launched on Monday, 23 September 2024. More information here FOREUM – Call open for application.